Michael Mandl, a longtime Emory University executive, has been named president and CEO of Emory Healthcare, the school's health system.
Cancer care in the U.S. faces a number of challenges involving care access, delivery and cost, despite making medical strides that resulted in a record number of cancer survivors in 2014, a new report finds.
A grass-roots petition to improve the affordability of cancer drugs is gathering signatures—and stories—after being posted online this month. Two weeks in, nearly 4,000 people have signed the petition asking the president, HHS and lawmakers to protest against high cancer drug prices.
Add one more remarkable thing to the list of what man's best friend can do: diagnose cancer.
Dr. Harold Varmus, 75, is retiring as director of the National Cancer Institute, the largest division of the National Institutes of Health.
A handful of cancer centers and their professional society are about to launch a big-data cancer quality initiative that will unlock previously inaccessible information on cancer care using millions of electronic health records.
The average price of computed tomography systems went up 15% in the past month as more hospitals purchased high-end scanners, including two new premium models that have been on the market for less than a year, according to the Modern Healthcare/ECRI Institute Technology Price Index.
The risk of dying following a colon cancer diagnosis is disproportionately higher among people who have a high school education or less, a study concludes. Both men and women who attended school for 12 years or fewer had significantly higher death rates from the disease.
Jacksonville, Fla.-based Baptist Health and the University of Texas MD Anderson Cancer Center are planning to create a joint cancer care program in 2015 that will serve north Florida.
Pharmaceutical giant Genentech has come under a maelstrom of criticism from hospitals for its decision to change its distribution methods for three widely used cancer drugs, and now the nation's largest not-for-profit health system is responding with a bold message.
The related issues of healthcare costs and the appropriateness of molecular and genetic testing will be considered by pathologists attending the annual meeting this week of the College of American Pathologists.
City of Hope, the not-for-profit comprehensive cancer center, reported that smaller gifts and an increase in its expenses led to a tighter operating margin in the first nine months of its fiscal 2014, which ends Sept. 30.